These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 836748)

  • 1. Screening for malignant hyperpyrexia.
    Nelson TE; Austin KL; Denborough MA
    Br J Anaesth; 1977 Feb; 49(2):169-72. PubMed ID: 836748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.
    Nelson TE; Denborough MA
    Clin Exp Pharmacol Physiol; 1977; 4(3):315-22. PubMed ID: 891045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
    Ginz HF; Girard T; Censier K; Urwyler A
    Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of susceptibility to malignant hyperpyrexia in swine.
    Okumura F; Crocker BD; Denborough MA
    Br J Anaesth; 1979 Mar; 51(3):171-6. PubMed ID: 435338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine.
    Sullivan JS; Denborough MA
    Br J Anaesth; 1981 Nov; 53(11):1217-22. PubMed ID: 7326167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
    Ording H; Skovgaard LT
    Acta Anaesthesiol Scand; 1987 Jul; 31(5):462-5. PubMed ID: 3630591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
    Hopkins PM; Ellis FR; Halsall PJ
    Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyfort GH; Dupuis BA
    Br J Anaesth; 1990 Jan; 64(1):64-6. PubMed ID: 2302378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine- or halothane-induced contractures of masseter muscle are similar to those of vastus muscle in normal humans.
    Melton AT; Antognini JF; Gronert GA
    Acta Anaesthesiol Scand; 1999 Aug; 43(7):764-9. PubMed ID: 10456818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procaine in malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1972 Dec; 4(5839):526-8. PubMed ID: 4642792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine.
    Fletcher JE; Adnet PJ; Reyford H; Wieland SJ; Stewart SL; Rosenberg H
    Anesthesiology; 1999 May; 90(5):1294-301. PubMed ID: 10319776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
    Ording H
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):405-8. PubMed ID: 2800978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of temperature, time and fascicle size on the caffeine contracture test.
    Britt BA; Endrenyi L; Scott E; Frodis W
    Can Anaesth Soc J; 1980 Jan; 27(1):1-11. PubMed ID: 7353184
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle.
    Williams JH; Holland M; Lee JC
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle contractures and adenosine triphosphate depletion in porcine malignant hyperthermia.
    Gronert GA
    Anesth Analg; 1979; 58(5):367-71. PubMed ID: 573559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H; Bendixen D
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia in humans--standardization of contracture testing protocol.
    Melton AT; Martucci RW; Kien ND; Gronert GA
    Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
    Ilias WK; Williams CH; Fulfer RT; Dozier SE
    Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.